Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Viruses
|
May 14, 2020
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
Peter Pushko, Irina Tretyakova
Expert Review of Vaccines
|
May 4, 2016
Vaccine platforms to control Lassa fever
Igor S Lukashevich, Peter Pushko
Intervirology
|
April 19, 2013
Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures
Peter Pushko, Paul Pumpens, Elmars Grens
Journal of Vaccines & Vaccination
|
November 3, 2015
Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus
Xiaohui Li, Peter Pushko, Irina Tretyakova
Pharmaceutics
|
September 28, 2024
Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment
Christine Mathew, Colin Tucker, Irina Tretyakova, et al.
Frontiers in Tropical Diseases
|
October 19, 2023
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits
Irina Tretyakova, Mark Tomai, John Vasilakos, et al.
The Journal of Infectious Diseases
|
March 4, 2014
DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice
Irina Tretyakova, Jason Hearn, Eryu Wang, et al.
Viruses
|
March 28, 2024
Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses
Peter Pushko, Igor S Lukashevich, Dylan M Johnson, et al.
Expert Review of Vaccines
|
April 8, 2016
DNA-launched live-attenuated vaccines for biodefense applications
Peter Pushko, Igor S Lukashevich, Scott C Weaver, et al.
Virology
|
September 23, 2017
Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice
Brian Nickols, Irina Tretyakova, Alexander Tibbens, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Viruses
|
May 14, 2020
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
Peter Pushko, Irina Tretyakova
Expert Review of Vaccines
|
May 4, 2016
Vaccine platforms to control Lassa fever
Igor S Lukashevich, Peter Pushko
Intervirology
|
April 19, 2013
Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures
Peter Pushko, Paul Pumpens, Elmars Grens
Journal of Vaccines & Vaccination
|
November 3, 2015
Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus
Xiaohui Li, Peter Pushko, Irina Tretyakova
Pharmaceutics
|
September 28, 2024
Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment
Christine Mathew, Colin Tucker, Irina Tretyakova, et al.
Frontiers in Tropical Diseases
|
October 19, 2023
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits
Irina Tretyakova, Mark Tomai, John Vasilakos, et al.
The Journal of Infectious Diseases
|
March 4, 2014
DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice
Irina Tretyakova, Jason Hearn, Eryu Wang, et al.
Viruses
|
March 28, 2024
Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses
Peter Pushko, Igor S Lukashevich, Dylan M Johnson, et al.
Expert Review of Vaccines
|
April 8, 2016
DNA-launched live-attenuated vaccines for biodefense applications
Peter Pushko, Igor S Lukashevich, Scott C Weaver, et al.
Virology
|
September 23, 2017
Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice
Brian Nickols, Irina Tretyakova, Alexander Tibbens, et al.
Page
of 5